Dry Mouth Clinical Trial
Official title:
Duration of Effect of Biotene Spray in Patients With Symptomatic Dry Mouth
Verified date | December 2020 |
Source | University of Rochester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To determine the duration of effect of a single dose of Biotène Moisturizing Mouth Spray in subjects who complain of a clinically dry mouth. The effect of the product will be compared to a control spray (water).
Status | Completed |
Enrollment | 37 |
Est. completion date | November 22, 2019 |
Est. primary completion date | November 22, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults who are in good general health and reply initially affirmatively to the question, "Do you feel that your mouth is too dry and causes you discomfort at times during the day other than on awakening from sleep?" This question is an adaptation of the question used successfully by Jose and others (2016) to recruit study subjects. - Adults who are able to communicate easily in English and who are able to demonstrate understanding of the study instructions. - Adults who are physically able to perform an unstimulated whole saliva flow rate (UWSFR) test and who produce 0.2 mL/min or less of saliva. Exclusion Criteria: - Adults under the care of a health professional specifically for xerostomia treatment, including those taking prescription systemic parasympathetic medications. - Adults who regularly "self-medicate" their xerostomia with water or other agents or products designed to treat their xerostomia and are unwilling or unable to cease use of the agent for at least 48 hours prior to the two test visits. - Adults who are primarily mouth breathers (i.e. mouth breathing secondary to nasal obstruction) - Adults who cannot consent for themselves or have physical/mental disabilities requiring a caregiver. - Adults with a known allergy to any of the ingredients in Biotène Spray (eg. dairy allergy) |
Country | Name | City | State |
---|---|---|---|
United States | University of Rochester Eastman Dental Center | Rochester | New York |
Lead Sponsor | Collaborator |
---|---|
University of Rochester |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean Duration of Action of Intervention | Participant will receive a dose of Biotene or placebo (water) and will be asked if their mouth is dry up to 2 hrs. The time at which their mouth becomes dry again will be the duration of action. | baseline up to 2 hours | |
Secondary | Mean Tolerability of Product | Subjects were asked to agree or disagree with the following statement where 1= strongly agree and 5- strongly disagree: The taste of the product was tolerable. | 2 hours | |
Secondary | Mean Acceptability of Product | Subjects were asked to agree or disagree with the following statement where 1= strongly agree and 5- strongly disagree: The thickness of the product was acceptable. | 2 hours | |
Secondary | Mean Continued Use of Project | Subjects were asked to agree or disagree with the following statement where 1= strongly agree and 5- strongly disagree: I would like to continue using this product. | 2 hours | |
Secondary | Mean Purchase Product Rating | Subjects were asked to agree or disagree with the following statement where 1= strongly agree and 5- strongly disagree: I would purchase this product to use on a regular basis. | 2 hours | |
Secondary | Mean Ease of Use of Product | Subjects were asked to agree or disagree with the following statement where 1= strongly agree and 5- strongly disagree: This product is easy to use. | 2 hours | |
Secondary | Mean Preference for Another Product | Subjects were asked to agree or disagree with the following statement where 1= strongly agree and 5- strongly disagree: I would prefer using another product. | 2 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04914208 -
Effect of Wearing Face Masks on Salivary Parameters and Halitosis
|
N/A | |
Completed |
NCT00601874 -
Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions
|
N/A | |
Completed |
NCT00601211 -
Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions
|
N/A | |
Completed |
NCT04152642 -
A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse
|
N/A | |
Completed |
NCT03215251 -
Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients in ICUs
|
N/A | |
Completed |
NCT04632004 -
Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health
|
N/A | |
Completed |
NCT05640362 -
Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial
|
N/A | |
Not yet recruiting |
NCT06412627 -
The Effect of Intervention About Dry Mouth and Thirst in Patients With Endotracheal Tube
|
N/A | |
Completed |
NCT04986501 -
Clinical Evaluation of MucoPEG™ for Xerostomia
|
N/A | |
Completed |
NCT04189081 -
Improvement of Dry Mouth Sufferers After Using an Experimental Dry Mouth Rinse Compared to a Water Control
|
N/A | |
Completed |
NCT05871580 -
Effect to the Photobiomodulation in the Burning Mouth Syndrome
|
N/A | |
Completed |
NCT06258603 -
Oral Care of Intubated Intensive Care Patient
|
N/A | |
Completed |
NCT01737307 -
Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy
|
Phase 2 | |
Completed |
NCT01647737 -
Green Tea Lozenges for the Management of Dry Mouth
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03874572 -
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
|
Phase 1 | |
Completed |
NCT03035825 -
Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients
|
N/A | |
Recruiting |
NCT05964959 -
A Mouth Education Program for Dry Mouth
|
N/A | |
Withdrawn |
NCT02123147 -
Examining the Immunological Process of Autoimmune Patients
|
N/A | |
Completed |
NCT01885065 -
Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients
|
N/A | |
Completed |
NCT03281486 -
"Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth
|
N/A |